HK Arbitrator Halts Commercialization Of Leukemia Treatment
A Cayman Islands pharmaceutical company has announced that an emergency arbitrator in Hong Kong has ordered a Chinese biopharma firm to stop commercializing a treatment for leukemia as the two companies...To view the full article, register now.
Already a subscriber? Click here to view full article